Kyndryl Announces Q4 & FY26 Results, Initiates Major Restructuring for $400-500M Annual Savings, and Provides FY27 Outlook

summarizeSummary

Kyndryl reported mixed Q4 and FY26 results with declining GAAP net income but announced a major restructuring plan expected to generate $400-500 million in annual savings, alongside a positive adjusted outlook for FY27 and significant share repurchases.

check_boxKey Events

• Q4 and Full-Year 2026 Financial Results

  For Q4 2026, revenues were $3.8 billion (down 1% reported, 5% constant currency YoY), net income was $17 million (down from $68 million YoY), and diluted EPS was $0.08 (down from $0.28 YoY). For the full fiscal year 2026, revenues were $15.1 billion (flat reported, down 3% constant currency YoY), net income was $198 million (down from $252 million YoY), and diluted EPS was $0.85 (down from $1.05 YoY). Adjusted EBITDA for FY26 increased 6% to $2.7 billion, and adjusted pretax income rose 21% to $581 million.

• Workforce Rebalancing Plan Approved

  The company approved workforce rebalancing actions on May 5, 2026, to streamline operations and optimize financial efficiency. These actions are expected to incur approximately $200 million in charges, primarily for severance, substantially in Q1 FY27. The plan is projected to result in annualized run-rate operating expense savings of $400 to $500 million in fiscal year 2028.

• Fiscal Year 2027 Outlook Provided

  Kyndryl provided an outlook for fiscal year 2027, projecting adjusted pretax income of $600 to $700 million (including workforce rebalancing charges) and free cash flow of $400 to $500 million. Constant-currency revenue is expected to be flat to down 2%.

• Significant Share Repurchase Activity

  In fiscal year 2026, Kyndryl repurchased 11.6 million shares for $304 million, with 3.3 million shares bought in Q4 for $49 million. Since the program's authorization in November 2024, the company has bought back 14.3 million shares for $398 million, representing 6% of its outstanding shares, with approximately $302 million of capacity remaining.

auto_awesomeAnalysis

Kyndryl's latest 8-K reveals a strategic pivot towards operational efficiency and profitability, marked by a significant workforce rebalancing plan. While GAAP net income and EPS saw a notable decline in Q4 and FY26, partly due to a non-recurring tax accrual, the company's adjusted metrics and forward guidance show a focus on improvement. The $200 million restructuring charge, while substantial, is projected to yield $400-500 million in annualized operating expense savings by fiscal year 2028, a highly material impact given the company's market capitalization. This aggressive cost-cutting, coupled with a robust share repurchase program (totaling $398 million since November 2024), signals management's commitment to enhancing shareholder value and strengthening financial fundamentals. The FY27 outlook for adjusted pretax income and free cash flow indicates a path to improved profitability and cash generation, which is critical, especially in light of the previously disclosed material weaknesses in internal financial controls and an ongoing SEC investigation into cash management. Investors will be watching for execution on these efficiency initiatives and their impact on future financial reports.